PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy; Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy.\', \'Department of Laboratory Medicine, Tor Vergata University Hospital, Rome, Italy.\', \'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.\', \'Department of Laboratory Medicine, Virology Unit, Tor Vergata University Hospital, Rome, Italy.\', \'Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy.\', \'Lifebrain Liguria, Via G.B. Monti, 109 R, Genoa, Italy.\', \'Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.\', \'Department of Functional Area of Integrated Care Services, Infectious Diseases Clinic, Tor Vergata University Hospital, Rome, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.\', \'Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy; Department of Laboratory Medicine, Tor Vergata University Hospital, Rome, Italy; Department of Experimental Medicine, University of Tor Vergata, Rome, Italy. Electronic address: massimo.pieri@uniroma2.it.\', \'Department of Laboratory Medicine, Tor Vergata University Hospital, Rome, Italy; Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1567-5769(21)00649-410.1016/j.intimp.2021.108013
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34339963
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all